Pages that link to "Q41039948"

The following pages link to Lovastatin induces apoptosis in malignant mesothelioma cells. (Q41039948):

Displaying 38 items.

• Statins and the risk of lung cancer: a meta-analysis (Q21559688) (← links)
• Primary pericardial mesothelioma unique case and literature review (Q26865926) (← links)
• HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2 (Q28201997) (← links)
• Pravastatin suppresses the interleukin-8 production induced by thrombin in human aortic endothelial cells cultured with high glucose by inhibiting the p44/42 mitogen activated protein kinase (Q28362055) (← links)
• Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells (Q28383033) (← links)
• Trypanosoma cruzi response to sterol biosynthesis inhibitors: morphophysiological alterations leading to cell death (Q28485411) (← links)
• Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans (Q34004787) (← links)
• Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins? (Q34107300) (← links)
• HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis (Q34605246) (← links)
• Primary pericardial mesothelioma (Q34795713) (← links)
• Epidemiology and prevention of colorectal cancer (Q35036350) (← links)
• Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease (Q35089446) (← links)
• Statin use and cancer risk: an epidemiologic review (Q36508082) (← links)
• Simvastatin induces apoptosis of fibroblast-like synoviocytes (Q37351735) (← links)
• Long-term statin use in patients with lung cancer and dyslipidemia reduces the risk of death (Q37520501) (← links)
• Targeting tumor cell metabolism with statins. (Q37981833) (← links)
• Tumor specific low pH environments enhance the cytotoxicity of lovastatin and cantharidin (Q39657136) (← links)
• Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin (Q39998302) (← links)
• In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent (Q40045931) (← links)
• Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro (Q40227158) (← links)
• Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas (Q40287001) (← links)
• Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells (Q40568933) (← links)
• Marketed drugs used for the management of hypercholesterolemia as anticancer armament (Q41080847) (← links)
• Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells (Q43714923) (← links)
• Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma (Q43747147) (← links)
• Phosphatase and tensin analog gene overexpression engenders cellular death in human malignant mesothelioma cells via inhibition of AKT phosphorylation (Q43939949) (← links)
• Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase (Q43983081) (← links)
• Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism (Q44062588) (← links)
• Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin (Q44403199) (← links)
• Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders. (Q46449145) (← links)
• Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies (Q46679447) (← links)
• Rho/ROCK pathway as a target of tumor therapy (Q46873057) (← links)
• Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells (Q47137660) (← links)
• Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma. (Q52642770) (← links)
• Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR). (Q53476716) (← links)
• Mitotic and in situ end-labeling apoptotic indices as prognostic markers in malignant mesothelioma. (Q53720232) (← links)
• NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma. (Q55355075) (← links)
• Phenoxodiol sensitizes metastatic colorectal cancer cells to 5-fluorouracil- and oxaliplatin-induced apoptosis through intrinsic pathway (Q97525022) (← links)